Purchases of vaccines for human use in Central America as of the third quarter of 2021 represented a value of $250 million, with Guatemalan companies being the main importers with $73 million.
Figures from the Trade Intelligence Unit of CentralAmericaData: [GRAFICA caption="Click to interact with the graphic"]
For the third quarter of 2021, an increase in regional imports of vaccines for veterinary use from Central America is observed with $34 million, Guatemala being the main buyer with $11 million.
Figures from the Trade Intelligence Unit of CentralAmericaData: [GRAFICA caption="Click to interact with the graphic"]
In the second quarter of 2022, purchases made by Salvadoran companies increased dramatically, reaching almost 500%, representing 45% of regional purchases with $67 million.
Figures from the Trade Intelligence Unit of CentralAmericaData: [GRAFICA caption="Click to interact with the graphic"]
For the second quarter of 2021, purchases of vaccines for veterinary use remained at $23 million, the main supplier for this period was the United States with $7 million.
Figures from the Trade Intelligence Unit of CentralAmericaData: [GRAFICA caption="Click to interact with the graphic"]
In 2020, Guatemala acquired the largest share of veterinary vaccines in the Central American market with $15.2 million, the main seller being the United States with 35.65%, equivalent to $12.4 million in the region.
Figures from the Trade Intelligence Unit of CentralAmericaData: [GRAFICA caption="Click to interact with the graphic"]
During 2020, companies in the region allocated $134 million for the import of vaccines for human use, and purchases from Russian companies increased 54% over what was reported in 2019.
Figures from the Trade Intelligence Unit of CentralAmericaData: [GRAFICA caption="Click to interact with the graph"]
The Ministry of National Defense of Guatemala tenders the supply of 20,020 vaccines against the influenza virus, which will be applied to members of the Army.
Guatemala Government Purchase 14393417:
"General characteristics:
-Dose in 0.5 ml pre-filled syringe.
-Transparent packaging
-Smooth texture
-Colorless, opalescent liquid consistency. Injectable solution, 0.5 ml pre-filled syringe with attached needle and label with vaccine composition information. From 4 strains of the northern hemisphere.
From January to September 2020, companies in the region invested $101 million for the purchase abroad of vaccines for human use, and purchases from Russian companies increased 34% compared to the same period in 2019.
Figures from the Trade Intelligence Unit of CentralAmericaData: [GRAFICA caption="Click to interact with the graph"]
During the first semester of 2020, companies from Central American countries bought abroad $23 million in vaccines for animal use, 18% more than what was reported for the same period in 2019.
Figures from the Trade Intelligence Unit of CentralAmericaData: [GRAFICA caption="Click to interact with graph"]
From January to June 2020, companies in the region allocated $71 million for the purchase of human vaccines abroad, and 60% of imports were made by companies in Panama, Guatemala and Honduras.
Figures from the Trade Intelligence Area of CentralAmericaData: [GRAFICA caption="Click to interact with graphic"]
From January to March 2020, companies in the region bought vaccines for human use abroad for $28 million, and 56% of total imports were made by companies in Costa Rica and Panama.
Figures from the Trade Intelligence Unit of CentralAmericaData: [GRAFICA caption="Click to interact with graphic"]
From January to September 2019, companies in the region bought vaccines for human use abroad for $154 million, 56% more than what was reported for the same period in 2018, a rise that is mainly explained by the behavior of imports in Panama.
Figures from the Trade Intelligence Unit at CentralAmericaData: [GRAFICA caption="Click to interact with graphics"]
During the first semester of 2019, companies from Central American countries bought $20 million in vaccines for animal use abroad, and 55% was imported by companies in Guatemala and Costa Rica.
Figures from the Trade Intelligence Unit at CentralAmericaData: [GRAFICA caption="Click to interact with graphics"]
In the first half of 2019, purchases of vaccines for human use in Central America totaled $122 million, 116% more than was reported in the same period in 2018.
Figures from the Trade Intelligence Unit at CentralAmericaData: [GRAPHIC caption="Click to interact with graphic"]
During the first quarter of 2019, companies in Central American countries purchased $8 million in vaccines for animal use abroad, and imports from the U.S. grew 12% over the same period in 2018.
Figures from the Trade Intelligence Unit at CentralAmericaData: [GRAPHIC caption="Click to interact with graphic"]